VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | The efficacy of tocilizumab in patients with advanced renal AA amyloidosis

Peter Kvacskay, MD, Heidelberg University Hospital, Heidelberg, Germany, briefly discusses the efficacy of tocilizumab in patients with renal AA amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter